Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome
Courtnee Clough(Cincinnati Children's Hospital Medical Center), Daniel T. Starczynowski(Cincinnati Children's Hospital Medical Center)
Cited by 4
Related Papers
The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity
|Nature Immunology|2017|139
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
|Science Translational Medicine|2019|88
The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia
|Leukemia|2021|60
The TYK2-P1104A Autoimmune Protective Variant Limits Coordinate Signals Required to Generate Specialized T Cell Subsets
|Frontiers in Immunology|2019|51